Source: Blackbird

Press Release: Bionique Testing : Global Mycoplasma Testing Market to Grow at a CAGR of 13.4% by 2023 - Key Vendors are Charles River Laboratories, Thermo Fisher, Roche Diagnostics, Merck Millipore, Lonza Group & Meridian Bioscience - Research and Markets

Read full article »

Bionique Testing's Competitors | Bionique Testing's News | Bionique Testing's Financials

Followers on Owler

150

Est. Annual Revenue

$5.0-25M

Est. Employees

250-500

CEO

Gladis Zamparo

CEO Approval Rating

82/100

Bionique is a New York-based biotechnology firm that provides mycoplasma testing services such as cell culture and lot release testing for the life science industry.